Back
Xeris Biopharma Holdings Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Buy
58
XERS
Xeris Biopharma Holdings
Last Price:
$3.44
Seasonality Move:
-20.03%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
The current trend is moderately bullish and XERS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Xeris Biopharma Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.42 | Buy |
| 20-day SMA: | 3.46 | Buy |
| 50-day SMA: | 3.27 | Buy |
| 200-day SMA: | 2.56 | Buy |
| 8-day EMA: | 3.44 | Buy |
| 20-day EMA: | 3.4 | Buy |
| 50-day EMA: | 3.26 | Buy |
| 200-day EMA: | 2.77 | Buy |
Xeris Biopharma Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 55.9 | Buy |
| Chaikin Money Flow: | 604170 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.2 - 3.58) | Buy |
| Bollinger Bands (100): | (2.68 - 3.34) | Buy |
Xeris Biopharma Holdings Technical Analysis
| Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Xeris Biopharma Holdings Stock
Is Xeris Biopharma Holdings Stock a Buy?
-
Xeris Biopharma Holdings share price is 3.50 while XERS 8-day simple moving average is 3.42, which is a Buy signal.
-
The stock price of XERS is 3.50 while Xeris Biopharma Holdings 20-day SMA is 3.46, which makes it a Buy.
-
Xeris Biopharma Holdings 50-day simple moving average is 3.27 while XERS share price is 3.50, making it a Buy technically.
-
XERS stock price is 3.50 and Xeris Biopharma Holdings 200-day simple moving average is 2.56, creating a Buy signal.
XERS Technical Analysis vs Fundamental Analysis
Buy
58
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy or a Sell?
-
Xeris Biopharma Holdings stock is rated a BuyThe current Xeris Biopharma Holdings [XERS] share price is $3.50. The Score for XERS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Xeris Biopharma Holdings Stock Info
Market Cap:
521.8M
Price in USD:
3.50
Share Volume:
604.2K
Xeris Biopharma Holdings 52-Week Range
52-Week High:
3.87
52-Week Low:
1.69
Buy
58
Xeris Biopharma Holdings (XERS)
is a Buy
Xeris Biopharma Holdings Share Price Forecast
-
What is the Xeris Biopharma Holdings stock price today?The Xeris Biopharma Holdings stock price is 3.50 USD today.
-
Will XERS stock go up or go down?Xeris Biopharma Holdings> share price is forecast to RISE/FALL based on technical indicators
-
Is Xeris Biopharma Holdings overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Xeris Biopharma Holdings is not overvalued.
Is Xeris Biopharma Holdings Stock a Buy?
-
Xeris Biopharma Holdings share price is 3.50 while XERS 8-day exponential moving average is 3.44, which is a Buy signal.
-
The stock price of XERS is 3.50 while Xeris Biopharma Holdings 20-day EMA is 3.40, which makes it a Buy.
-
Xeris Biopharma Holdings 50-day exponential moving average is 3.26 while XERS share price is 3.50, making it a Buy technically.
-
XERS stock price is 3.50 and Xeris Biopharma Holdings 200-day simple moving average is 2.77, creating a Buy signal.
Fundamental Analysis of Xeris Biopharma Holdings
Is Xeris Biopharma Holdings a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.05 per share.
Technical Analysis of Xeris Biopharma Holdings
Should I short Xeris Biopharma Holdings stock?
-
XERS Moving Average Covergence Divergence (MACD) indicator is 0.06, suggesting Xeris Biopharma Holdings is a Buy
-
Xeris Biopharma Holdings Relative Strength Index (RSI) is 55.9, which suggest Xeris Biopharma Holdings is overbought
-
The Bollinger Bands (25) for Xeris Biopharma Holdings is (3.2 - 3.58), which suggest Xeris Biopharma Holdings is a Buy
-
The Bollinger Bands (100) for Xeris Biopharma Holdings is (2.68 - 3.34), which suggest Xeris Biopharma Holdings is a Buy
* Xeris Biopharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.